Pharma technology and training firm targets India and China
A two-pronged business model incorporating specialised products and training for the pharmaceutical sector has allowed Dublin company Innopharma to extend its market reach to 20 countries in the eight years since its launch without external investment.
Innopharma founder Ian Jones estimated internally-funded investment in the company’s process analytical technologies at €12 million to date.
“We are debt-free. We haven’t taken on any external investment. We have invested ourselves and we’ve had R&D supports from...
Subscribe from just €1 for the first month!
Exclusive offers:
All Digital Access + eReader
Trial
€1
Unlimited Access for 1 Month, €19.99 Monthly thereafter
*New subscribers only
Annual
€200
€149 For the 1st Year
Unlimited Access for 1 Year
Quarterly
€55
€42
90 Day Pass
2 Yearly
€315
€248
Unlimited Access for 2 Years
Team Pass
Get a Business Account for you and your team
Related Stories
Tom Maguire: Tax changes we make now could help business for years
The way we did business a few months ago may never return – so the opportunity is to make changes that will both aid recovery and set us up well for our new futures
The Daily Briefing
What’s coming up today and what you might have missed
The Daily Briefing
What’s coming up today and what you might have missed.
